Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure-Reference-Cited by-同舟云学术

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure

Published:2016-09 Issue:1 Volume:13 Page:31-49
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Rowland Andrew,van Dyk Madelé,Mangoni Arduino A.,Miners John O.,McKinnon Ross A.,Wiese Michael D.,Rowland Angela,Kichenadasse Ganessan,Gurney Howard,Sorich Michael J.

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/17425255.2016.1229303

Reference126 articles.

1. Integrating Clinical Pharmacology Concepts in Individualized Therapy With Tyrosine Kinase Inhibitors

2. Opportunities and Challenges in the Development of Experimental Drug Combinations for Cancer

3. Clinical pharmacology of tyrosine kinase inhibitors becoming generic drugs: the regulatory perspective

4. Role of Tyrosine Kinase Inhibitors in Cancer Therapy

5. Tyrosine Kinases as Targets for Cancer Therapy

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase inhibitors in cancers: Treatment optimization – Part II;Critical Reviews in Oncology/Hematology;2024-08

2. Population Pharmacokinetics in Oncology and Its Clinical Applications;Pharmaceutics;2024-05-25

3. Supporting gut health with medicinal cannabis in people with advanced cancer: potential benefits and challenges;British Journal of Cancer;2023-10-26

4. Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significance;Pharmacology & Therapeutics;2023-08

5. Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges;Cancers;2023-06-22